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Treatment resistant latent reservoirs remain a barrier to cure HIV, but the maintenance and properties of
these reservoirs are not completely understood. 2-LTR circular HIV DNA has been used to assess ongoing
viral replication in HAART treated patients. However, the half-life of this DNA form is still debated with
conﬂicting in vivo and in vitro data. Prior in vitro studies have focused on cell lines or short lived activated
cells in cultures of brief duration, while in vivo studies have the added complications of cell migration,
division, and death. Therefore, we monitored the stability of 2-LTR circles in primary CD4þT cells in a
month long culture and compared it to the stability of integrated HIV DNA and T cell receptor excision
circles (TRECs), another circular DNA form that is thought to be stable. We found that 2-LTRs, along with
TRECs, were stable, suggesting 2-LTRs do not necessarily indicate ongoing replication.
& 2013 Elsevier Inc. All rights reserved.Introduction
Although highly active antiretroviral therapy (HAART) is effec-
tive at controlling HIV replication, it is not a cure as a reservoir of
treatment resistant cells persists. These latently infected cells,
mainly consisting of resting CD4þT cells, can release infectious
virus upon stimulation (Chun et al., 1997; Finzi et al., 1999). How
this reservoir is maintained in the face of HAART is still an open
question. While several hypotheses exist, one possible explanation
is that a low level of ongoing replication occurs, in spite of therapy
either in sanctuary sites or due to insufﬁcient drug levels, that
replenishes the reservoir over time (Coiras et al., 2009; Lafeuillade
and Stevenson, 2011; Palmer et al., 2008). Some evidence for this
hypothesis is the existence of circular HIV DNA forms including
2 long terminal repeat circles (2-LTRs) in patients on HAART
(Sharkey et al., 2000) and the increase in such circles upon
Raltegravir intensiﬁcation (Buzon et al., 2010). This evidence
presupposes a short half-life of these circular forms. However,
there is still debate over the longevity of 2-LTR circles (Brussel
et al., 2003; Butler et al., 2002; Gillim-Ross et al., 2005; Murray
et al., 2012; Pierson et al., 2002; Sharkey et al., 2000, 2005; Zhu
et al., 2011). While several in vivo studies have suggested 2-LTRs
are short-lived (Murray et al., 2012; Sharkey et al., 2005; Zhu et al.,
2011), it is difﬁcult to determine if decreases in 2-LTRs reﬂect
degradation of the circles themselves or other complicating factors
such as cell half-life, division, and migration. In vitro studies alsoll rights reserved.
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While some studies using cell lines suggest 2-LTRs are short-
lived (Sharkey et al., 2000), other studies using cell lines indicate
long 2-LTR half-lives, particularly when cell division and viability
are controlled (Butler et al., 2002; Pierson et al., 2002). However,
these in vitro studies did not use physiologically relevant cells and
did not culture the cells for a long period of time (∼10 days at
most) (Butler et al., 2002; Pierson et al., 2002). Therefore, we chose
to examine the stability of 2-LTRs in primary CD4þT cells infected
in vitro in a month long culture as some in vivo studies suggest that
2-LTR circles have a half-life between 8 and 25 days (Murray et al.,
2012; Zhu et al., 2011). We also examined the stability of T cell
receptor excision circles (TRECs) as a comparison as TRECs are
often assumed to be long-lived in vivo (Hazenberg et al., 2001;
Somech, 2011).Results and discussion
We ﬁrst examined the dynamics of total HIV DNA and 2-LTRs in
infected primary CD4þT cells in a short time-course, similar to
previous in vitro studies. We treated the cells with 10 ng/mL IL-7 to
maintain the cells in culture and with the integrase inhibitor
Raltegravir to increase the levels of 2-LTR circles to more easily
detectable levels. We found that total HIV DNA peaked at 2 days
post infection while 2-LTR circles peaked 4 days post infection
(Fig. 1A), consistent with the literature (Gillim-Ross et al., 2005).
Total HIV DNA quickly declined until it reached levels similar to
those of 2-LTR circles (∼day 4 post infection), suggesting that most
of the HIV DNA consisted of 2-LTRs by that time (Fig. 1A). This is
consistent with the short half-life of linear unintegrated HIV DNA
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decline in 2-LTRs during the 10 day culture, similar to prior in vitro
studies using cell lines (Butler et al., 2002; Pierson et al., 2002).
As one of the major criticisms of previous 2-LTR stability
studies in vitro was the short duration of the experiments
(Sharkey et al., 2005), we wanted to examine the stability of
2-LTRs in primary cells for a longer period of time. In addition, we
also wanted to compare the stability of 2-LTRs with integrated HIV
DNA and T cell receptor excision circles (TRECs), another type of
circular DNA, both of which are thought to persist for the life of the
cell. TRECs are generated during TCR recombination and have been
used to assess thymic output and the age and division history of T
cells (den Braber et al., 2012; Hazenberg et al., 2001; Jamieson
et al., 1999; Somech, 2011). While TRECs are assumed to be long-
lived based on in vivo data (Douek et al., 1998; Hazenberg et al.,
2001; Livak and Schatz, 1996; Somech, 2011; van Gent et al., 2011),
in vitro data is limited and the precise half-life of TRECs is currently
unknown (Hazenberg et al., 2001; Somech, 2011; van Zelm et al.,
2007). Therefore, we decided to measure TRECs in addition to 2-
LTRs to compare the stability of different circular DNA forms and to
add to both the TREC and HIV literature. As TRECs are enriched in
naïve CD4þT cells (Douek et al., 1998), we decided to examine
both TRECs and 2-LTR circles in naïve cells cultured for a month
in vitro.
We therefore infected naïve CD4þT cells with X4 tropic HIV
again in the presence of IL-7 and Raltegravir for the reasons stated
above. As integrase inhibitors do not completely inhibit integration
in our in vitro system (>98% inhibition based on an infected,
untreated control, data not shown), we were able to quantify 2-LTR
circles, integrated HIV DNA and TRECs. To control for any cell
division, we labeled the cells with CFSE and quantiﬁed cell division
during the culture. We also monitored cell viability to control for
cell death.
We found that both 2-LTR circles and integrated HIV DNA were
stable in naïve cells during the 30 day culture (Fig. 1B). We next
examined levels of TRECs over time in vitro and found that TRECs
were stable in naïve cells (Fig. 1C). To determine the apparent half-
lives of the HIV intermediates and TRECs, we used linear regres-
sion to generate a best ﬁt line through the plot of log10 quantities
per cell over time as previously described (Brussel et al., 2003). We
found that none of the slopes of the best ﬁt lines were statistically
different than zero, indicating no signiﬁcant decline in 2-LTRs,
integrated HIV DNA or TRECs (Fig. 1D).
As cell death or proliferation could affect our results, we
examined cell viability and division. We found that the naïve cells
did not divide during the month long culture, while bulk CD4þT
cells did (Fig. 1E), likely due to central memory homeostatic
proliferation. This is consistent with prior data indicating that
naïve cells only divide in the presence of IL-7 in ∼50% of donors
(Azevedo et al., 2009). Therefore, cell division did not affect our
results. Additionally, we found no signiﬁcant change in the
viability of the cells treated with IL-7 over time, whereas infected
cells without additional cytokines died within 7 days (data not
shown). Thus, neither cell death nor proliferation altered our
ﬁndings that 2-LTRs and TRECs are stable in vitro.
Our results indicate that 2-LTRs, like TRECs, are stable in
primary CD4þT cells in vitro. While some studies have suggested
that 2-LTRs are long-lived in vivo (Brussel et al., 2003), recent
reports suggest that 2-LTR circles have relatively short half-lives
in vivo, between 8 and 28 days (Murray et al., 2012; Zhu et al.,
2011). However, these studies admit that the calculations could be
due to cellular half-lives or migration of cells containing 2-LTR
circles. Our data suggests that the short in vivo half-lives of 2-LTRs
are likely due to these confounding in vivo factors rather than the
stability of the circles themselves. Additionally, the reported short
half-life of circular HIV DNA in vivo suggests our month-longculture is sufﬁcient to determine whether the stability of the cells
or the 2-LTRs were responsible for 2-LTR declines in patients.
While other in vitro studies showed 2-LTR circles were stable in
cell lines (Butler et al., 2002; Pierson et al., 2002), their short time
courses and use of non-primary cells limited their ability to
address both the stability of 2-LTRs in vivo and the ability to
measure ongoing replication using this circular HIV intermediate.
Our studies show that 2-LTRs are stable in primary over a 30 day
culture and that 2-LTR degradation cannot be responsible for their
apparent short half-life in vivo. These results have important
implications for the HIV ﬁeld.
Previous studies suggested that 2-LTRs could be used as a
marker for ongoing replication due to their short half-lives
(Sharkey et al., 2000, 2005). Our results suggest that the presence
of 2-LTRs is not sufﬁcient to identify new rounds of replication.
Together, our data showing the stability of 2-LTRs in primary cells
along with in vivo studies indicating 2-LTRs but not integrated HIV
DNA disappear over time suggests that the proliferation or the
migration of cells with 2-LTRs occurs in vivo, confounding inter-
pretations of ongoing replication. However, this is not to say that
2-LTRs will not increase during new rounds of replication, merely
that 2-LTRs alone may not be sufﬁcient to identify these periods.
Overall, our data suggest that 2-LTRs themselves are stable in
CD4þT cells but dynamics or migration of infected cells results in
the shorter apparent half-life of 2-LTRs in vivo. Thus, the mere
presence of 2-LTRs is not sufﬁcient to determine periods of
ongoing replication.Materials and methods
Cells
Primary CD4þT cells were puriﬁed from leukapheresis-
enriched PBMC using Rosette Sep (Stemcell Technologies) and
were obtained through the University of Pennsylvania's Center for
AIDS Research Human Immunology Core. After infection, cells
were cultured in RPMI containing 20% heat inactivated FCS and
10 ng/mL IL-7 (R&D Biosystems).Cell sorting
CD4þT cells were puriﬁed as above and were stained with
CD45RO PE-Texas Red (Beckman Coulter) and CCR7 PECy7 (BD
Bioscience). Naïve CD4þT cells (CD45RO−, CCR7þ) were sorted
using a FACSAria II Cell Sorter (BD Bioscience) and were >98% pure.CFSE staining
An aliquot of infected cells was labeled using CellTrace CFSE
Cell Proliferation Kit (Invitrogen) as per the manufacturer's
instructions immediately after infection.Virus and infection
NL4-3 viral stocks were prepared by 293 T transfections by the
University of Pennsylvania's Center for AIDS Research molecular
virology core. Cells were sorted as described above and spinocu-
lated the same day at a concentration of 1×107 cells/mL at 1200×g
at 25 °C for 2 h with 280 ng of p24 per 1e6 cells. After spinocula-
tion, cells were washed twice in CO2 independent media (Invitro-
gen) and treated with 50 µg/mL Dnase 1 (Roche) and 10 mMMgCl2
to remove plasmid DNA. Cells were then cultured in the presence
of 1 µM Raltegravir (Merck) and 1.25 µM saquinavir (Roche).
Fig. 1. 2-LTR circles, TRECs and integrated HIV DNA are stable over time in primary CD4þT cells. In (A) CD4þT cells were infected with HIV in the presence of the
integrase inhibitor Raltegravir. Cells were cultured in 10 nm/mL IL-7. Total HIV DNA and 2-LTR circles were measured between 0 and 10 days post infection. A representative
of three experiments is shown. In (B) naïve CD4þT cells were infected with HIV and cultured in the presence of Raltegravir, saquinavir, and IL-7. 2-LTR circles and integrated
HIV DNAwere measured over a period of 30 days. 2-LTRs were not above baseline at t¼0. A representative of three experiments is shown. In (C) TRECs were measured in the
same cells shown in B. Bars represent the standard deviations of the measurements (A–C). A representative of two experiments is shown. In (D) the log10 of the values in B
and C were graphed over time and a linear regression was performed to calculate half-lives of the different HIV DNA species. In (E) infected bulk CD4þT cells or naïve CD4þT
cells were labeled with CFSE and cell division measured over time. Graphs shown are for 30 days post infection.
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2-LTRs, total HIV DNA (using RU5 primers), and integrated HIV
DNA were quantiﬁed as previously described (Graf et al., 2011;
Pace et al., 2012). Integrated HIV DNA was ﬁrst measured at 2 days
post infection to conserve sample. TRECs were measured as
previously described (Douek et al., 1998).
Statistical analysis
Linear regression analysis was performed using Graphpad
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